Anindya Bose1*, Somnath Mukherjee2

1Dr. B. C. Roy College of Pharmacy and Allied Health Sciences, Dr. Meghnad Saha Sarani, Durgapur-713 206, India

2Laboratory Automation Services, HCL Technologies Ltd, New Town, Rajarhat, Dist North 24 Parganas, Kolkata - 700 156.

*Corresponding Author:

E-mail address:

Mobile no. +91 343 2532678

Telephone no. +91 343 2532679


There is an urgent demand for rectification of the “one-size-fits-all” method of treatment using personalized medicine model. Personalized medicine involves the determination of an individual’s unique genetic profile with respect to disease risk and drug response to optimize preventive health care strategies while people are still well or at the earliest stages of disease. Personalized medicine also helps to address the serious adverse drug reactions (ADRs) that not only are very costly but are responsible for thousands of deaths each year. However, the potential benefits of personalized medicine cannot be realized until certain obstacles in its adoption in its adoption are removed. These obstacles include uncertain regulatory requirements, insufficient insurance reimbursement for diagnostic tests linked to pre-emptive care, incomplete legal protections to prevent genetic discrimination, the lack of a comprehensive healthcare information technology system, and the present “one-size-fits-all” medical education system.

Keywords: Personalized medicine, adverse drug reactions (ADRs), patent, single nucleotide polymorphisms (SNPs).

Journal Resources

Open Source


Abstracting and Indexing

Social Media